Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1994-7-12
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0174-304X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
54
|
pubmed:dateRevised |
2008-1-16
|
pubmed:meshHeading |
pubmed-meshheading:8208355-Anticonvulsants,
pubmed-meshheading:8208355-Humans,
pubmed-meshheading:8208355-Infant,
pubmed-meshheading:8208355-Infant, Newborn,
pubmed-meshheading:8208355-Spasms, Infantile,
pubmed-meshheading:8208355-Treatment Outcome,
pubmed-meshheading:8208355-Vigabatrin,
pubmed-meshheading:8208355-gamma-Aminobutyric Acid
|
pubmed:year |
1994
|
pubmed:articleTitle |
Vigabatrin in newly diagnosed infantile spasms.
|
pubmed:publicationType |
Letter,
Review
|